Insulin Delivery Devices Market by Product (Insulin Pens, Insulin Syringes, and Insulin Pumps) and Distribution Channel (Diabetes Clinics and Centers, Retail Pharmacy, Hospital Pharmacy, and Online Sales)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers forecast and analysis for the insulin delivery devices market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the insulin delivery devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the insulin delivery devices market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the insulin delivery devices market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Product segment is benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the insulin delivery devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the insulin delivery devices market on a global and regional basis. 

The study provides a decisive view on the insulin delivery devices market by segmenting the market based on product, distribution channel, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on the product, the insulin delivery devices market has been segmented into insulin pens, insulin syringes, and insulin pumps. Insulin pens hold the majority share of the product segment, due to increased demand for improved diabetes management and minimally invasive property of pens. The distribution channel segment has been segmented into diabetes clinics and centers, retail pharmacy, hospital pharmacy, and online sales.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries including the U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for insulin delivery devices based on individual segments and types in all regions and countries.

The report also includes detailed profiles of end players, such as Eli Lilly and Company, Medtronic plc., B. Braun Melsungen AG, Sanofi S.A., Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Biocon Ltd., Becton, Dickinson and Company, Valeritas, Inc., MannKind Corporation, and Insulet Corporation, among others.

This report segments the global insulin delivery devices market as follows:

Global Insulin Delivery Devices Market: By Product

	Insulin Pens
	Insulin Syringes
	Insulin Pumps

Global Insulin Delivery Devices Market: By Distribution Channel

	Diabetes Clinics and Centers
	Retail Pharmacy
	Hospital Pharmacy
	Online Sales

Global Insulin Delivery Devices Market: By Region

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa